Market Tracker

10/31 12:17pm ET
1.70
Real-Time Quote
 -0.02 / -1.16%
Today’s Change
1.35
Today|||52-Week Range
8.41
-72.27%
Year-to-Date
No recent news for Exelixis Inc.

Today’s Trading

Previous close1.72
Today’s open1.75
Day’s range1.69 - 1.77
Volume846,080
Average volume (3 months)3,922,612
Market cap$331.7M
Dividend yield--
Data as of 12:01pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-44.57%
Earnings growth (this year)-10.63%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-33.96%
P/E ratioNM
Price/Sales36.00
Price/Book4.74

Competitors

 Today’s
change
Today’s
% change
ARWRArrowhead Research C...-0.33-4.90%
FLXNFlexion Therapeutics...-0.55-2.76%
BSTCBiospecifics Technol...-0.33-0.81%
ENZEnzo Biochem Inc+0.01+0.19%
Data as of 12:16pm ET, 10/31/2014

Financials

Last reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$31.3M
Annual profit (last year)-$244.8M
Net profit margin-781.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer, Senior VP &
Controller
Deborah Burke
Corporate headquarters
South San Francisco, California

Forecasts